Drug intelligence / Profile preview

ethyl loflazepate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Ethyl loflazepate is a benzodiazepine derivative used primarily as an anxiolytic and sedative. It also possesses anticonvulsant and skeletal muscle relaxant properties. Ethyl loflazepate acts as a prodrug, with its main pharmacological effects mediated by its active metabolite, descarboxyloflazepate, which is a benzodiazepine receptor agonist. The drug exerts its effects by acting as a positive allosteric modulator of the GABA-A receptor complex, enhancing the inhibitory neurotransmitter GABA's effect in the central nervous system. It has been approved for use in conditions such as anxiety (including post-trauma anxiety), generalized anxiety disorder (GAD), panic attacks, obsessive–compulsive disorder, delirium tremens, and anxiety associated with severe neuropathic pain[1][5][6]. Ethyl loflazepate is not approved for marketing in the United States but is commercialized under various brand names in other countries.

Brand names
MeilaxRonlaxVictan
Other names
ethyl loflazepateethyl fluclozepateethyl flucozepate
02

Targets

BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on ethyl loflazepate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethyl loflazepate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call